Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 2Pancreatic Diseases 2Carcinoma, Pancreatic Ductal 2

Interventions

Gemcitabine 8130-nm albumin-bound paclitaxel 6Albumin-Bound Paclitaxel 5napabucasin 2Paclitaxel 2MK-4721 2Irinotecan 2Blood Specimen Collection 2sonidegib 1parecoxib 1lutetium Lu 177 dotatate 1irinotecan sucrosofate 1copper dotatate CU-64 1Taxes 1Surveys and Questionnaires 1Sunitinib 1Rehabilitation 1Postoperative Care 1Piperacillin, Tazobactam Drug Combination 1Oxaliplatin 1Ocoxin 1Needles 1Methods 1Lutetium-177 1Lutetium 1Leucovorin 1Histocompatibility Testing 1HhAntag691 1Fluorouracil 1Duodenoscopes 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pancreatic Diseases × MK-4721 × Gastrointestinal × Clear all
NCT01608711 2017-05-16

A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002

Astellas Pharma Inc

Phase 2 Completed
2 enrolled
Gastrointestinal

Pancreatic Diseases, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal

NCT00902291 2015-09-14

A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer

Astellas Pharma Inc

Phase 2 Completed
205 enrolled
Gastrointestinal

Pancreatic Diseases, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡